{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:26Z","timestamp":1788498986680,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder, often beginning in adolescence and associated with reproductive, metabolic, and psychological complications. The present study evaluated whether adolescent patients meeting the 2023 adolescent-specific PCOS criteria (Rotterdam phenotypes A and B) exhibit poorer mental health or lower quality of life (QoL) in adulthood compared with those with Rotterdam PCOS phenotypes C and D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted among women previously hospitalized in pediatric endocrinology wards and diagnosed with PCOS during adolescence. Clinical data, hormonal profiles, and comorbidities were extracted from medical records. The study group [SG] comprised patients with Rotterdam PCOS phenotypes A and B, while the comparison group [CG] included phenotypes C and D and adolescents at risk of PCOS. In adulthood, participants completed a 66-item survey including self-reported BMI, menstrual symptoms, Ferriman-Gallwey scoring, comorbidity assessment, the Patient Health Questionnaire-9 (PHQ-9), and the WHOQOL-BREF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 46 individuals completed the survey, including 32 participants in the SG and 14 in the CG. The median age was 22.5 years in the SG and 21.5 years in the CG. All participants were Polish. During adolescence, SG and CG differed in testosterone levels (p = 0.0007) and number of patients with menstrual irregularities (p = 0.006). In adulthood, no significant between-group differences were observed in BMI, Ferriman-Gallwey scores, PHQ-9 outcomes, or WHOQOL-BREF domain scores. The distribution of depressive symptom severity did not differ significantly. Moreover, no correlations were found between QoL or depressive symptoms and BMI change, disease duration or hirsutism. However, mean PHQ-9 scores in both groups indicated clinically relevant depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adult women diagnosed with PCOS (Rotterdam phenotypes A and B) in adolescence did not exhibit poorer quality of life or increased depressive symptoms compared with women presenting Rotterdam PCOS phenotypes C and D or adolescents previously classified as being at risk of PCOS. No significant differences were observed between groups in PHQ-9 or WHOQOL-BREF scores, nor were these outcomes related to BMI, hyperandrogenism, or disease duration. Both groups demonstrated elevated depressive symptom levels, highlighting the need for longitudinal studies on long-term psychological outcomes in PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1793628","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:09Z","timestamp":1788496029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adult psychological outcomes among women with different adolescent PCOS presentations"],"prefix":"10.3389","volume":"17","author":[{"given":"Maria Ma\u0142gorzata","family":"Nowak-Cio\u0142ek","sequence":"first","affiliation":[{"name":"Students' Scientific Association at the Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Paczyna","sequence":"additional","affiliation":[{"name":"Students' Scientific Association at the Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Grygiel","sequence":"additional","affiliation":[{"name":"Students' Scientific Association at the Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sokal","sequence":"additional","affiliation":[{"name":"Students' Scientific Association at the Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017baneta","family":"Malczyk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skrzy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zachurzok","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5603\/GP.a2021.0042","article-title":"Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome","volume":"92","author":"Zachurzok","year":"2021","journal-title":"Ginekol Pol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2019.07.008","article-title":"Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome","volume":"32","author":"\u00c7oban","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79895","article-title":"Comparative analysis of psychosocial outcomes and quality of life among nulligravida, primigravida, and multigravida women diagnosed with polycystic ovary syndrome","volume":"17","author":"Rehman","year":"2025","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2025.1520641","article-title":"Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome","volume":"6","author":"Yang","year":"2025","journal-title":"Front Glob Womens Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4467\/20843879PR.20.006.12003","article-title":"Obraz w\u0142asnego cia\u0142a i poczucie jako\u015bci \u017cycia u m\u0142odych kobiet z zespo\u0142em policystycznych jajnik\u00f3w","volume":"25","author":"Zi\u00f3\u0142kowska","year":"2020","journal-title":"Probl Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovary syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12916-020-01861-x","article-title":"Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood","volume":"18","author":"Tay","year":"2020","journal-title":"BMC Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1590\/s0034-8910.2014048004912","article-title":"Cut-off point for WHOQOL-BREF as a measure of quality of life of older adults","volume":"48","author":"Silva","year":"2014","journal-title":"Rev Saude Publica"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18203\/2320-1770.ijrcog20223292","article-title":"Quality of life of infertile women as measured by WHOQOL-BREF in Bangladesh","volume":"12","author":"Ishrat","year":"2022","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5152\/jtgga.2012.39","article-title":"Health-related quality of life among different PCOS phenotypes of infertile women","volume":"13","author":"Dilbaz","year":"2012","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02799.x","article-title":"Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women","volume":"118","author":"Kumarapeli","year":"2011","journal-title":"BJOG"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15020376","article-title":"Determinants of quality of life and satisfaction with life in women with polycystic ovary syndrome","volume":"15","author":"Rzo\u0144ca","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.53555\/jptcp.v31i6.7253","article-title":"Comparison of depressive symptoms in women having PCOS with and without obesity","volume":"31","author":"Bibi","year":"2024","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.09.025","article-title":"Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)","volume":"94","author":"Bhattacharya","year":"2010","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.309","article-title":"Characterization of depression phenotypes in women with polycystic ovary syndrome","volume":"116","author":"Dayo","year":"2021","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.69980\/ajpr.v28i1.155","article-title":"The association between polycystic ovary syndrome and depression in Saudi women: a cross-sectional study","volume":"28","author":"Edris","year":"2025","journal-title":"Am J Psychiatr Rehabil"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.110.EP1302","article-title":"Mental health assessment in women with PCOS: evaluating anxiety and depression using GAD-7 and PHQ-9","volume":"110","author":"Krstic","year":"2025","journal-title":"Endocrine Abstracts"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.jadohealth.2024.11.185","article-title":"Do adolescents with menstrual disorders, including PCOS, have higher scores on the PHQ-9 compared to those without","volume":"76","author":"Ratti","year":"2025","journal-title":"J Adolesc Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1511-112","article-title":"Do anxiety and depression statuses differ in different polycystic ovary syndrome phenotypes","volume":"46","author":"Akda\u011f Cirik","year":"2016","journal-title":"Turk J Med Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des114","article-title":"Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome","volume":"27","author":"Moran","year":"2012","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12905-022-01983-9","article-title":"Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study","volume":"22","author":"Bahadori","year":"2022","journal-title":"BMC Womens Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-021-00811-2","article-title":"Health-related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study","volume":"14","author":"Fatemeh","year":"2021","journal-title":"J Ovarian Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70501","article-title":"Available treatments and adjunctive therapies for polycystic ovary syndrome patients of reproductive age: a scoping review","volume":"16","author":"Cochran","year":"2024","journal-title":"Cureus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050680","article-title":"Pharmacological and non-pharmacological interventions for polycystic ovary syndrome (PCOS) in Indian women: A systematic review and meta-analysis","volume":"18","author":"Maan","year":"2025","journal-title":"Pharm (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2357737","DOI":"10.1080\/07853890.2024.2357737","article-title":"The latest reports and treatment methods on polycystic ovary syndrome","volume":"56","author":"Sta\u0144czak","year":"2024","journal-title":"Ann Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1793628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:10Z","timestamp":1788496030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1793628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1793628"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1793628","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1793628"}}